Favourable survival of allogeneic stem cell transplantation after prior cytogenetic response to IFN in chronic myelogenous leukemia (CML).

被引：0
|
作者：
Reiter, A [1 ]
Maywald, O [1 ]
Metzgeroth, G [1 ]
Berger, U [1 ]
Hochhaus, A [1 ]
Pfirrmann, M [1 ]
Gnad, SU [1 ]
Kolb, HJ [1 ]
Gratwohl, A [1 ]
Bunjes, D [1 ]
Schaefer, UW [1 ]
Zander, AR [1 ]
Finke, J [1 ]
Arnold, R [1 ]
Fauser, AA [1 ]
Schwerdtfeger, R [1 ]
Sahakyan, L [1 ]
Hasford, J [1 ]
Hehlmann, R [1 ]
机构：
[1] Univ Heidelberg, Klinikum Mannheim, Fak Klin Med Mannheim, Med Univ Klin 3, Mannheim, Germany
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4839
引用
收藏
页码：323B / 323B
页数：1
相关论文
共 50 条
  • [1] Cytogenetic response to prior treatment with interferon-α is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia
    O Maywald
    M Pfirrmann
    U Berger
    L Breitscheidel
    A Gratwohl
    H-J Kolb
    D W Beelen
    A Tobler
    G Metzgeroth
    S U Gnad
    A Hochhaus
    J Hasford
    R Hehlmann
    A Reiter
    [J]. Leukemia, 2006, 20 : 477 - 484
  • [2] Cytogenetic response to prior treatment with interferon-α is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia
    Maywald, O
    Pfirrmann, M
    Berger, U
    Breitscheidel, L
    Gratwohl, A
    Kolb, HJ
    Beelen, DW
    Tobler, A
    Metzgeroth, G
    Gnad, SU
    Hochhaus, A
    Hasford, J
    Hehlmann, R
    Reiter, A
    [J]. LEUKEMIA, 2006, 20 (03) : 477 - 484
  • [3] Stem cell transplantation (PBSCT) for chronic myelogenous leukemia (CML).
    Massumoto, C
    Hamerschlack, N
    Ferreira, E
    Pietrocola, M
    Katz, F
    Kutner, JM
    Alves, A
    [J]. BLOOD, 2001, 98 (11) : 262B - 262B
  • [4] ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
    BUCKNER, CD
    CLIFT, RA
    STORB, R
    THOMAS, ED
    [J]. EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 486 - 486
  • [5] Late cytogenetic and molecular response to interferon-α (IFN-α) in chronic myelogenous leukemia (CML).
    Nosari, A
    Perego, R
    Pungolino, E
    Cornacchini, G
    Gargantini, L
    Morra, E
    [J]. BLOOD, 1998, 92 (10) : 627A - 627A
  • [6] Long term leukemia-free survival (LFS) after allogeneic stem cell transplantation in patients with chronic myelogenous leukemia
    Reiter, E
    Greinix, HT
    Schulenburg, A
    Keil, F
    Rabitsch, W
    Mannhalter, C
    Schwarzinger, I
    Fischer, G
    Leitner, G
    Dieckmann, K
    Schneider, B
    Lechner, K
    Kalhs, P
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S83 - S83
  • [7] Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemia
    Reiter, E
    Greinix, HT
    Brugger, S
    Keil, F
    Rabitsch, W
    Mannhalter, C
    Schwarzinger, I
    Höcker, P
    Fischer, G
    Dieckmann, M
    Hinterberger, W
    Linkesch, W
    Schneider, B
    Lechner, K
    Kalhs, P
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 : S86 - S88
  • [8] Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia
    Kantarjian, HM
    O'Brien, S
    Cortes, JE
    Giralt, SA
    Rios, MB
    Shan, JQ
    Giles, FJ
    Thomas, DA
    Faderl, S
    De Lima, M
    Garcia-Manero, G
    Champlin, R
    Arlinghaus, R
    Talpaz, M
    [J]. BLOOD, 2002, 100 (05) : 1590 - 1595
  • [9] Fasciitis after allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia
    Kim, KW
    Yoon, CH
    Kay, CS
    Kim, HJ
    Lee, EH
    Park, SY
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2003, 9 (01) : 33 - 36
  • [10] Absence of influence of prior interferon alfa (IFN alpha) therapy on the outcome of allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML).
    Tomas, IF
    Steegman, IL
    Requena, MI
    Soria, VGG
    FernandezRanada, IM
    [J]. BLOOD, 1995, 86 (10) : 3859 - 3859
12345